← brief for 2026-10-13 · Slowing decline

A Study of Luspatercept in People With Anemia

Trial No results yet Not peer reviewed

Key takeaways

A new trial is starting to test a drug called luspatercept. It aims to improve low blood count in people with kidney disease. There are no results yet. The study will also check if the drug is safe.

Who did this work

Run by Memorial Sloan Kettering Cancer Center.
Sites: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) · Memorial Sloan Kettering Monmouth (Limited Protocol Activities) · Memorial Sloan Kettering Bergen (Limited Protocol Activities) · Memorial Sloan Kettering at Suffolk - Commack (Limited Protocol Activities) · Memorial Sloan Kettering Westchester (Limited Protocol Activities) · Memorial Sloan Kettering Cancer Center

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-10-13
https://clinicaltrials.gov/study/NCT07725497